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In oral squamous cell carcinoma (OSCC), the cellular differentia-
tion in the invasion front as well as the mode of invasion are
crucial for the tumour behaviour. These parameters belong to the
so-called new malignancy grading, which yields a better prog-
nostic value than the conventional Broder’s grading system (Bryne
et al, 1992). Therefore, an analysis of the extracellular matrix in
the invasion front of OSCC may improve the understanding of
tumour cell–matrix interactions during malignant growth.
The epithelium–stroma interface is delineated by a distinct
extracellular matrix structure, the basement membrane (BM).
Structural irregularities of carcinoma BMs, including the loss of
BM material, have been known for some time. In OSCC the extent
of BM defects correlates with invasive and metastatic potential
(Harada et al, 1994; Kobayashi et al, 1995). In areas with BM
defects the invading carcinoma cells may come into contact with
the abundant stromal fibronectin matrix.
Recent results have given rise to a new definition of laminin and
fibronectin as molecule families (Mandel et al, 1994; Kosmehl
et al, 1996). Laminin is a heterotrimeric molecule with an a, b and
g chain. Laminin isoforms arise from an exchange of single chains
and can be identified in situ by chain-specific antibodies. Laminin
isoforms are deposited in a maturation and differentiation-depen-
dent manner. Present knowledge of the laminin chain pattern in
normal and diseased oral squamous epithelium is only incomplete.
Whilst laminin is quantitatively the most important non-collage-
neous matrix protein of the BM, fibronectin is nearly ubiquitously
distributed. Fibronectin is a high-molecular-mass glycoprotein
with a molecular polymorphism generated by alternative
processing of the pre-mRNA (alternative splicing) or by post-
translational modifications of the protein itself (de novo glycosyla-
tion). Soluble plasma fibronectin (dimeric, alternatively spliced in
the IIICS region) is synthesized by hepatocytes and is found in
body fluids. Cellular fibronectin is a larger molecule with an
additional domain in the IIICS region and is constituent of the
extracellular matrix in dimeric or multimeric cross-linked form.
Variants of cellular fibronectin arise from further alternative
splicing or de novo O-linked glycosylation in the IIICS domain.
In contrast to the ubiquitously distributed common cellular
fibronectin, the ED-A and the ED-B fibronectin as well as the de
novo glycosylated fibronectin isoforms are limited to areas with
structural tissue modulation, embryonic tissues, reparative
processes and neoplasias (Loridon-Rosa et al, 1990; Xia and Culp,
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Summary The expression of laminin and fibronectin isoforms varies with cellular maturation and differentiation and these differences may well
influence cellular processes such as adhesion and motility. The basement membrane (BM) of fetal oral squamous epithelium contains the
laminin chains, a2, a3, a5, b1, b2, b3, g1 and g2. The BM of adult normal oral squamous epithelium comprises the laminin chains, a3, a5, b1,
b3, g1 and g2. A re-expression of the laminin a2 and b2 chains could be shown in adult hyperproliferative, dysplastic and carcinomatous lesions.
In dysplasia and oral squamous cell carcinoma (OSCC), multifocal breaks of the BM are present as indicated by laminin chain antibodies. These
breaks correlate to malignancy grade in their extent. Moreover, in the invasion front the a3 and g2 chain of laminin-5 can immunohistochemically
be found outside the BM within the cytoplasm of budding carcinoma cells and in the adjacent stroma. The correlation between the morphological
pattern of invasive tumour clusters and a laminin-5 immunostaining in the adjacent stroma may suggest, first, that a laminin-5 deposition outside
the BM is an immunohistochemical marker for invasion and second, that OSCC invasion is guided by the laminin-5 matrix. Expression of
oncofetal fibronectins (IIICS de novo glycosylated fibronectin and ED-B fibronectin) could be demonstrated throughout the stromal
compartment. However, the ED-B fibronectin synthesizing cells (RNA/RNA in situ hybridization) are confined to small stroma areas and to single
stroma and inflammatory cells in the invasion front. A correlation of the number of ED-B fibronectin synthesizing cells to malignancy grade could
not be seen. ED-B fibronectin mRNA-positive cells seem to be concentrated in areas of fibrous stroma recruitment with a linear alignment of
stromal fibro-/myofibroblasts (desmoplasia). Double staining experiments (ED-B fibronectin in situ hybridization and a-smooth muscle actin
immunohistochemistry) indicated that the stroma myofibroblasts are a preferential source of ED-B fibronectin. In conclusion, in OSCC, a fetal
extracellular matrix conversion is demonstrable. Tumour cells (laminin a2 and b2 chain) and recruited stromal myofibroblasts (oncofetal ED-B
fibronectin) contribute to the fetal extracellular matrix milieu. © 1999 Cancer Research Campaign
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et al, 1997). The isoforms are identifiable using specific mono-
clonal antibodies (Borsi et al, 1987; Mandel et al, 1992;
Carnemolla et al, 1996).
Extracellular matrix molecules influence differentiation, prolif-
eration, migration, and have stabilizing and separating functions
(Kosmehl et al, 1996). To our knowledge, a comparative study
focusing on the modulation of the laminin chain pattern in fetal,
normal adult, hyperproliferative, or dysplastic oral epithelium
and in OSCC of different malignancy grade has not yet been
conducted. Although an immunohistochemical study on the
expression of so-called oncofetal fibronectins (ED-B and de novo
glycosylated fibronectin) in relation to the formation of an inva-
sive phenotype of neoplastic oral epithelium has already been
published (Mandel et al, 1994), the source of the ED-B fibronectin
within the carcinoma remains unclear.
MATERIALS AND METHODS
Tissue material
Twenty-seven surgical specimens of squamous cell carcinoma of
the oral cavity (tumour invasion front), five samples of normal
adult non-neoplastic, two samples of normal fetal (5th–6th month
of gestation), five samples of hyperplastic and three samples of
dysplastic oral squamous epithelium were available for histo-
logical and immunohistochemical investigations. All samples are
derived from the Clinic of Maxillofacial Surgery of the Friedrich
Schiller University of Jena. Blocks of fresh tissue measuring
4 ´ 4  ´ 4 mm were immediately shock-frozen in isopropanol,
cooled by liquid nitrogen and stored at –75°C. The diagnosis was
made on conventional haematoxylin and eosin (H&E)-stained
serial sections and confirmed in the corresponding paraffin-
embedded tissue. Histological grading of malignancy was
performed using the method reported by Bryne et al (1992). For
correlation analysis the tumours were grouped into well-differenti-
ated G1 carcinomas and into moderate to poorly differentiated
G2/3 carcinomas.
Immunohistochemistry
Cryostat sections of the respective frozen tissue samples were
fixed in ice-cooled acetone for 15 min and subjected to immuno-
histochemistry. Primary antibodies used are listed in Table 1. The
immunostaining for collagen type IV was used as reference for the
BM. The laminin chain immunostainings were interpreted behind
this background.
Immunohistochemical staining was performed using the alka-
line phosphatase monoclonal anti-alkaline phosphatase (APAAP)
method. The primary antibody was incubated for 30 min at room
temperature. After washing with Tris buffer, sections were treated
with rabbit anti-mouse immunoglobulin (diluted 1:70, Dako,
Denmark), and then with the mouse APAAP complex (Dako,
Denmark). Both incubations were carried out for 30 min at room
temperature. To increase the staining intensity, the incubation
with the rabbit anti-mouse immunoglobulin and with the APAAP
complex was repeated twice. Naphthol-AS-biphosphate (Sigma,
USA) and new fuchsin (Merck, Germany) were used as sub-
strate and developer respectively. To inhibit endogenous tissue
enzyme activity, the developing solution was supplemented with
0.25 mmol l–1 levamisole (Sigma, USA). As negative control, the
primary antibody was replaced by non-immune serum.
Quantitative evaluation of the laminin chain and
collagen type IV immunostainings and statistical
analysis
The BM defects for the laminin chains a3, a5, b1, g1 and collagen
type IV were semiquantitatively evaluated in 30 tumour cell
clusters per case at the invasion front according to the criteria
introduced by Kobayashi et al (1995) and scored as follows:
• continuous linear staining (no BM defects, score 0)
• loss of staining in less than 10% of the tumour–stromal
interface per tumour cell nest (minor BM defects, score 1)
• loss of staining in less than 50% of the tumour–stromal
interface per tumour cell nest (moderate BM defects, score 2)
• loss of staining in more than 50% of the tumour–stromal
interface per tumour cell nest (BM defects to a large extent,
score 3).
The number of tumour cell clusters with minor, moderate and
major BM defects are presented as mean values ± standard devia-
tion (s.d.).
For statistical evaluation of laminin chain and collagen type IV
defects in relation to malignancy grade (G1 and G2/3) the products
of the score and number of related tumour cell clusters were added
up for each tumour. Statistical analysis was done using the
Mann–Whitney  U-test (SPSS, Microsoft). P < 0.05 was regarded
as statistically significant.
In situ hybridization
The cDNA fragment of the ED-B portion of human fibronectin
was inserted as a 272 bp BamHI fragment into BamHI digest
pBluescriptIIKS+ vector (Stratagene, La Jolla, CA, USA). Sense
or antisense RNA probes were generated by in vitro transcription
of the XbaI or EcoRI linearized plasmid using digoxigenin-
labelled uridine triphosphate as substrate (DIG RNA Labelling
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Table 1 Primary antibodies and their reactive determinants
Antigen Clone Dilution References
Lam a1 chain goat polyclonal 1:100 Santa Cruz
Biotechnology, Inc.
(sc 6016)
Lam a2 chain 5H2 1:5000 Engvall et al, 1990
Lam a3 chain BM165 1:5000 Rousselle et al, 1991
P3E4 (epiligrin) 1:100 Wayner et al, 1993
Lam a5 chain 4C7 1:10 000 Tiger et al, 1997
Lam b1 chain 4E10 1:20 000 Wewer et al, 1983
Lam b2 chain C4 1:3000 Sanes and Chiu, 1983
Lam b3 chain 6F12 1:50 Marinkovich et al, 1992
Lam g1 chain 2E8 1:500 Wewer et al, 1983
Lam g2 chain GB3 1:20 Hsi and Yeh, 1986
Collagen type IV CIV22 1:50 Odermatt et al, 1984
Fibronectin IST4 1:20 Zardi et al, 1980
(all variants)
ED-B+ fibronectin BC-1 1:20 Carnemolla et al, 1989
CGS1 1:50 Carnemolla et al, 1996
(recombinant
antibody)
De novo glycosylated fn 5C10 1:20 Mandel et al, 1992
FDC-6 1:10–1:20 Matsuura and
Hakamori, 1985
Von Willebrand factor F8/86 1:50 Hruban et al, 1887
a smooth muscle actin 1A4 1:50 Skalli et al, 1986Kit, Boehringer Mannheim, Germany) and T3 or T7 RNA poly-
merase. Unincorporated nucleotides were removed by ethanol
precipitation. The precipitate was dissolved in 100-ml diethylpyro-
carbonate treated and RNAase inhibitor containing water. The
transcripts were analysed by agarose gel electrophoresis and dot
blot assay.
In situ hybridization was carried out on 7 to 10-mm-thick
sections of immediately snap-frozen tissue. Sections were heated
for 2 min at 50°C to fix the RNA in the tissue. The sections were
allowed to air dry for 30 min and then fixed in 4% (w/v)
paraformaldehyde in phosphate-buffered saline (PBS) for 20 min
at 4°C. After washing in PBS (1 ´ 5 min) and 2 ´ standard saline
citrate (SSC) (2 ´ 5 min), the prehybridization solution was
applied on each slide for 60 min at 37°C. The prehybridization
solution contained 4 ´ SSC, 10% dextran sulphate, 1 ´ Denhardt’s
solution, 2 mM EDTA, 50% de-ionized formamide, 100 mg ml–1
herring sperm DNA and 100 mg ml–1 tRNA. After removal of this
solution, each section was covered with 100 ml of prehybridization
solution containing 200–1000 ng ml–1 of DIG-labelled antisense
cRNA probe and incubated at 37°C overnight.
As hybridization controls, the antisense cRNA probe was
replaced by ED-B sense cRNA or was completely omitted from
the hybridization to evaluate the quality of the colour detection
system. After hybridization, unbound probe was washed off from
the sections as follows: 1 ´ 5 min with 2 ´ SSC at 37°C, 3 ´ 5 min
with 60% formamide in 0.2 ´ SSC at 37°C, and 2 ´ 5 min with
2 ´ SSC at room temperature.
Hybridized DIG-labelled cRNA probes were detected using the
components of the DIG Nucleic Acid Detection Kit (Boehringer
Mannheim, Germany) following the manufacturer’s recommended
protocol. Colour reaction was carried out for up to 24 h at room
temperature.
The ED-B fibronectin mRNA is situ hybridization and the
corresponding immunohistochemistry using the monoclonal anti-
body BC1 and the recombinant antibody CGS1 was performed on
13 OSCC. Four carcinomas were well-differentiated (G1), and
nine carcinomas were moderately to poorly differentiated (six G2
and three G3). The number of in situ hybridization signal bearing
cells was counted in 10 HPF (´ 40) and was correlated to
tumour grade (G1, G2/3). To prove statistical significance, the
Kruskal–Wallis and Mann–Whitney U-tests were applied (SPSS,
Microsoft).
Double staining procedure for a-smooth muscle
actin/Von Willebrand factor and ED-B fibronectin
synthesis
A combination of in situ hybridization and PAP technique was
used for double staining of cells showing ED-B fibronectin
synthesis and positivity for alpha-smooth muscle actin or Von
Willebrand factor. First, the mRNA in situ hybridization for ED-B
fibronectin was performed as described. Second, after thorough
rinsing in Tris buffer the PAP procedure for a-smooth muscle actin
or Von Willebrand factor visualization was carried out (Kosmehl
et al, 1996).
RESULTS
Analysis of laminin chain distribution
Normal adult oral squamous epithelium
In the squamous cell epithelium–stroma interface, a continuous,
narrow and sharply contoured BM was demonstrated by collagen
type IV immunohistochemistry. An identical BM staining was
achieved using antibodies against the laminin chains, a3 (BM165)
(Figure 1D), a3 (epiligrin), a5, b1, b3, g1 and g2. The a1, a2 and
b2 laminin chains were not present in the epithelial BM.
Fetal oral squamous epithelium
In addition to the laminin chains of adult oral squamous epithelium
(a3 (BM165), a3 (epiligrin), a5, b1, b3, g1, and g2) the a2 and b2
chain are also expressed (Figure 1A–C). The immunostaining of
the BM was continuous and sharply contoured. The a1 chain
could not be demonstrated in the epithelial BM.
Hyperplastic and dysplastic oral squamous epithelium
The laminin chains a3 (BM165), a3 (epiligrin), a5, b1, b3, g1 and
g2 were detected in the epithelial BM. Compared to normal adult
oral squamous epithelium the BM showed irregularities that
included thickening and a blurred outline. Additionally, a BM
staining for the b2 chain could be demonstrated (Figure 1E). A a2
laminin chain staining was seen in the BM of few pseudopapillas.
Occasionally, small segments with a focal loss of laminin chain
immunostaining could be observed in dysplastic lesions. The a1
chain could not be demonstrated in the epithelial BM.
Oral squamous cell carcinoma
The profile of laminin chain expression was similar to that
observed in hyperplastic and dysplastic oral squamous epithelium,
namely the expression of the laminin a3 (BM165), a3 (epiligrin),
a5,  b1,  b2 (Figure 1F), b3,  g1 and g2 chains which could be
demonstrated around the tumour cell nests. Whereas the a1 chain
could not be demonstrated in the BM of the carcinomatous epithe-
lium, an a1 immunostaining was achieved in relation to stromal
fibro-/myofibroblasts (Figure 2C). An a2 laminin chain staining
could be observed only focally.
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Table 2 Extent of BM defects in the invasion front of oral squamous cell carcinomas in correlation to malignancy grade. The mean value (+/– standard
deviation) of the number of tumour nests with no, minor, moderate or large extended BM defects of all G1 and G2/3 tumours is presented evaluating 30 tumour
cell nests per case
Laminin No BM defects Minor BM defects Moderate BM defects BM defects to a large extent
chain
G1 G2/3 G1 G2/3 G1 G2/3 G1 G2/3
a3 18.8 (± 8.85) 5.0 (± 7.36) 5.8 (± 4.02) 7.3 (± 4.60) 3.4 (± 3.34) 8.8 (± 4.25) 2.0 (± 3.23) 8.9 (± 7.92)
a5 14.6 (± 9.74) 1.6 (± 2.75) 6.5 (± 3.24) 5.1 (± 4.74) 4.7 (± 3.74) 8.4 (± 4.38) 4.2 (± 6.81) 14.9 (± 9.71)
b1 13.0 (± 9.25) 2.9 (± 4.93) 8.0 (± 4.27) 5.1 (± 4.03) 5.0 (± 3.43) 8.6 (± 3.50) 4.0 (± 6.70) 13.3 (± 8.06)
g1 5.9 (± 7.82) 0.4 (± 0.81) 5.9 (± 5.06) 2.6 (± 3.61) 7.2 (± 3.85) 8.0 (± 4.18) 11.0 (± 9.52) 19.0 (± 7.63)
Collagen type IV 12.5 (± 8.83) 2.9 (± 3.82) 7.2 (± 3.93) 6.1 (± 4.40) 5.4 (± 2.91) 8.8 (± 3.67) 4.9 (± 5.53) 12.2 (± 9.23)1074 H Kosmehl et al
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Figure 1 Fetal oral mucosa with immunohistochemical demonstration of the laminin a3 chain (A, BM165), laminin a2 chain (B) and laminin b2 chain (C) in the
squamous epithelial BM region (30th week of gestation, ´150, without counterstaining). In normal adult epithelium the BM represents a sharp contoured line
(D, laminin a3 chain, BM165, ´150, haematoxylin counterstaining). In hyperplastic epithelium a smooth contoured BM with reexpression of the laminin b2 chain
is revealed (E, ´150, without counterstaining). The reexpression of the b2 chain is retained in OSCC BM (F, ´300, haematoxylin counterstaining).
Demonstration of numerous BM breaks in a less differentiated OSCC by immunostaining for the laminin a3 chain (G, BM165, ´300, without counterstaining)
and the laminin g2 chain (H, ´300, without counterstaining)Laminin and fibronectin isoforms in oral squamous cell carcinoma 1075
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Figure 2 Demonstration of laminin-5 (a3b3g2) in the invasion front of a less differentiated OSCC. In addition to the BM staining a focal deposition of the a3
chain (A, BM165, ´300, without counterstaining) and the g2 chain (B, ´300, without counterstaining) is shown beneath budding tumour cell complexes. A
laminin a1 chain staining of the BM is not achieved (C, OSCC, ´150, haematoxylin counterstaining). Immunostaining of oncofetal ED-B fibronectin in the BM
region as well as diffuse in the stromal compartment of fetal oral mucosa (D, 19th week of gestation, clone BC-1, ´300 haematoxylin counterstaining). Strong
immunostaining of ED-B fibronectin within the stromal compartment of moderate differentiated OSCC using the recombinant antibody CGS1 (E, ´150,
haematoxylin counterstaining). OSCC stromal myofibroblasts synthesize ED-B fibronectin as demonstrated by double labelling (ED-B mRNA in situ
hybridization, black and a-smooth muscle actin immunohistochemistry, brown) (F, ´150, without counterstaining). In stromal areas with linear alignment of the
fibro-/myofibroblasts (desmoplasia) numerous stromal cells bear the ED-B mRNA in situ hybridization signal (G, ´300, without counterstaining). In addition to
stromal cells a subset of endothelial cells synthesize ED-B fibronectin as demonstrated by double labelling (H, OSCC, ED-B mRNA in situ hybridization, black
and factor VIII associated antigen immunohistochemistry, brown, ´300, without counterstaining)Two further observations were remarkable: first, the immuno-
labelling of all observed laminin chains was discontinuous, indi-
cating a focal loss of laminin chains in the epithelial BM region of
the invasion front (Figure 1G–H, Table 2). The semiquantitatively
assessed loss of laminin chains and collagen type IV showed
significant differences between G1 and G2/3 carcinomas (a3:
P = 0.0017, a5: P = 0.0017, b1: P = 0.0032, g1: P = 0.0264 and
collagen type IV: P = 0.0037).
Second, an increased staining was achieved for the a3, b3 and
g2 chains in invasive areas. These chains were seen in the cyto-
plasm of budding tumour cells and outside the BM region in the
stroma of the invasion front (Figure 2A–B).
Whereas the antibodies directed against the laminin a3 chain
(BM165 and P3H4) extensively stained stromal areas in the inva-
sion front, a comparable but quantitatively lesser b3 and g2 chain
staining was visible in the corresponding stroma of the invasion
front. The monoclonal antibody P3H4 also labelled basal lamina
structures of stromal myofibroblasts.
Analysis of oncofetal fibronectin distribution and
synthesis
Oncofetal fibronectin immunohistochemistry
In normal adult and hyperplastic oral mucosa, ED-B fibronectin
and de novo glycosylated fibronectin were absent. Embryonal
mucosa showed a moderate immunoreactivity for oncofetal
fibronectins in the BM region and in the subepithelial stroma
(Figure 2D).
In the 13 OSCC ED-B fibronectin (BC1, CGS1) and de novo
glycosylated fibronectin (5C10, FDC-6) could be demonstrated by
immunohistochemistry. The immunostaining for ED-B fibronectin
and de novo glycosylated fibronectin were restricted to the tumour
stroma. The immunostaining pattern of both antibodies against
ED-B fibronectin was identical, but the staining of the recombi-
nant antibody was slightly more intensive (Figure 2E). Whilst the
well-differentiated carcinomas exhibited focal deposits within the
stroma and at the invasion front, the moderately/poorly differenti-
ated carcinomas showed a diffuse staining throughout the tumour
stroma compartment and at the invasion front. The ED-B
fibronectin deposits at the invasion front in well-differentiated
carcinomas correlated to the histological aspect of a clumsy inva-
sive carcinoma growth. In addition to the stroma positivity, ED-B
fibronectin could also be found immunohistochemically in tumour
vessels and in some blood vessels of the pre-existing tissue
adjacent to the invasion front (Figure 2H).
ED-B fibronectin RNA/RNA in situ hybridization
In eight out of 13 carcinomas (two G1 and six G2/3 carcinomas)
ED-B fibronectin mRNA could be shown by in situ hybridization.
A clear labelling was observed in cells of the stromal compartment
(Figure 2F). In G1 carcinomas numerous positive stromal cells
with myofibroblastic appearance were identified within the newly
formed stroma of verrucous carcinoma projections, in keeping
with the immunohistochemical ED-B fibronectin demonstration.
In contrast to the diffuse ED-B fibronectin immunostaining in
the G2/G3 carcinomas, the ED-B fibronectin synthesis was limited
only to stromal cell foci. The foci were located in newly induced
stroma with parallel alignment of myofibroblastic stroma cells
(desmoplasia) (Figure 2G). Moreover, a few marked fibroblastic
and inflammatory cells could focally be seen at the invasion front.
A relation between the number of mRNA containing stromal cells
and tumour grade could not be observed. This was also evidenced
by statistical analysis. Using double labelling of ED-B fibronectin
in situ hybridization and a-smooth muscle actin immunostaining
numerous ED-B fibronectin mRNA containing stromal cells were
identified as myofibroblasts (Figure 2F).
DISCUSSION
Laminin chains in the normal oral squamous
epithelium
The laminins represent a continuously growing family of proteins
(Kosmehl et al, 1996; Miner et al, 1997), whose members are
endowed with different biological functions (Strassburger et al,
1998). Because skin and oral squamous epithelia bear structural and
functional resemblances, their similar laminin chain composition
is not surprising (Rousselle et al, 1991; Sollberg et al, 1992).
According to the visualized chains the following laminin isoforms
are possible in the BM of normal oral mucosa: laminin-5, -6 and -10.
Laminin-5 (a3b3g2) is a typical component of epithelial BMs
and is considered the biochemical equivalent of the anchoring fila-
ments fixing basal keratinocytes to the BM. Its significance for the
mechanical resistance and protective function of the epithelium
has been discussed in the literature (Rousselle et al, 1991, 1995).
The reports in the literature concerning the distribution of the
a1 chain in human tissues were based mostly on the application of
the antibody 4C7. Recently, however, the monoclonal antibody
4C7 was shown to recognize the laminin a5 chain of laminin-10
(a5b1g1) and laminin-11 (a5b2g1) (Tiger et al, 1997). Our data
highlight the recently described widespread distribution of
laminin-10 in the BMs of various tissue types (Durkin et al, 1997;
Miner et al, 1997; Kikkawa et al, 1998).
In contrast to the adult oral squamous epithelium, embryonal
oral squamous epithelium showed the presence of the a2 and b2
chains. The following laminin isoforms may be present in the BM
of embryonal mucosa: laminin-2, -4, -5, -6, -7, -10 and -11. The a2
chain is mainly associated with the basal lamina of mesenchymal
cells (Leivo et al, 1988). More recent studies indicate that the adult
epidermal BM contains little (Sollberg et al, 1992; Squarzoni et al,
1997) or no (Hori et al, 1994) laminin a2 chain. Dystroglycan is
an important non-integrin receptor for the laminin a2 chain. It is
considered crucial for embryonal BM formation (Williamson et al,
1997) and is present in embryonal oral squamous epithelium
(unpublished personal observation). Therefore, the expression of
the laminin a2 chain in embryonal oral mucosa may be a prerequi-
site for normal oral morphogenesis.
The a1 chain together with the b1 and g1 chains forms the
prototypic EHS laminin (laminin-1) and is expressed in different
BMs (Ryan et al, 1996). Nevertheless, we were unable, however,
to detect the laminin a1 chain in embryonal, normal adult, hyper-
and dysplastic or carcinomatous epithelial BM using a polyclonal
antibody. The specificity of this antibody was checked using
normal adult human kidney, with results matching those of Tiger
and co-workers (Tiger et al, 1997). Our findings confirm the
limited distribution of the laminin a1 chain observed in rodent
tissues (Ekblom et al, 1990; Klein et al, 1990).
Re-expression of the a2 and b2 chains in hyperplastic,
dysplastic and carcinomatous oral squamous
epithelium
Because the presence of laminin a2 and b2 chains is a regular
finding in embryonic tissues (Iivanainen et al, 1994), their
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features in BM composition; the following heterotrimeric laminin
molecules are possible: laminin-2, -4, -5, -6, -7, -10 and -11.
A re-expression of the b2 chain occurs in vivo not only in
OSCC, but also in basal cell carcinoma of the skin (Sollberg et al,
1992), in proliferating benign and malignant lesions of the breast
(Kosmehl et al, 1996), and regularly in cultured carcinoma cells
(the so-called developmental switch) (Miner et al, 1994; Wewer
et al, 1994).
Structural basement membrane alterations in OSCC
demonstrated with antibodies specific for different
laminin chains
Basement membrane defects could not be seen at light microscope
level in normal or hyperplastic oral squamous epithelium.
However, using immunolabelling in hyperplastic lesions a
doubling of the width was observed comparable with the findings
of Kainulainen et al (1997) in oral lichen planus. In dysplasia and
carcinoma BM structural irregularities, including reduplication,
splitting, attenuation and breaks (Ueno et al, 1997) have been well
documented by electron microscopy. Moreover, immunohisto-
chemical BM defects and a loss of corresponding integrins in head
and neck squamous cell carcinomas have been reported (Downer
et al, 1993; Harada et al, 1994; Kobayashi et al, 1995; Kosmehl
et al, 1995a, 1996). In this study, multifocal breaks of BM
continuity were observed in the invasion zone of all carcinomas,
regardless of the laminin chain specificity of the antibodies. The
number and extent correlated well with the malignancy grade.
These findings are in line with the results of Harada et al (1994)
and Kobayashi et al (1995), who found that an increased loss of
BM material (antibodies to EHS-laminin) is associated with a rise
in metastatic potential. The semiquantitative evaluation of BM
defects reveals differences among the various laminin chains.
These differences are not surprising, given that laminin isoform
expression is contingent on tissue maturation which varies in the
carcinoma invasion front.
The result of laminin a3 chain immunolabelling should be
emphasized: first, number and extent of BM defects demonstrated
with the a3 chain antibodies (BM165 and P3E4) were fewer and
less pronounced than the BM defects demonstrated with antibodies
specific to the other laminin chains. Second, in the invasion front
there were foci with a strong a3 chain staining outside the original
BM region close to budding tumour cells. For the g2 chain of
laminin-5, an invasion-associated increased synthesis was demon-
strated in adenocarcinoma of the colon (Pyke et al, 1994; Ueno
et al, 1997). In addition, Kainulainen et al (1997) reported a strong
deposition of the g2 chain outside the BM in invasive areas of
OSCC. As determined in serial sections, the immunostaining of
the a3 chain is more extensive than that of the g2 chain. The
absence of a clear corresponding b1/2 or g1 chain staining, as well
as the demonstrated cytoplasmic accumulation of laminin chains
in budding OSCC cells, hint to a disturbed molecule assembly.
Comparable results were recently described by Sordat (1998) for
colorectal neoplasia.
The focal loss of structural BM organization, and the presence
of the g2 chain and particularly the a3 laminin chain on tumour
cell surface and in the stroma adjacent to invasive carcinoma cell
clusters, may support the tumour cell invasion (Kosmehl et al,
1996). Invasion mediated via newly deposited laminin-5
containing BM has previously been suggested in pancreatic
adenocarcinoma (Tani et al, 1997). In case of OSCC cells the inva-
sion related laminin-5 immunostaining is not associated with an
organized BM as shown in vitro (Berndt et al, 1997). Whilst the
role of laminin-5 as a strong adhesive for keratinocytes in vivo and
in vitro is generally accepted (Rousselle et al, 1991), the ability
to promote keratinocyte migration is still controversial (O’Toole
et al, 1997). Nevertheless, the majority of experiments suggest
that it can promote cell motility (Zhang et al, 1996; Tani et al,
1997).
ED-B fibronectin synthesis indicates tumour stroma
recruitment
Our results show that, except for some highly differentiated carci-
nomas, oncofetal fibronectins (ED-B fibronectin, de novo glyco-
sylated fibronectin) permeate the whole stromal compartment of
OSCC (cp. Mandel et al, 1994). In contrast to OSCC, breast and
colon carcinomas display only focal oncofetal fibronectin deposits
if at all (Kaczmarek et al, 1994; Pujuguet et al, 1996). As pre-
viously described, newly formed vessels within tumour stroma
contain ED-B fibronectin (Castellani et al, 1994). We have found
that some, possibly growth factor-stimulated, blood vessels neigh-
bouring the invasion front are also ED-B fibronectin-positive. The
new phage antibody CGS1 (Carnemolla et al, 1996) generates
comparable staining patterns to the mouse monoclonal antibody
BC1, proving to be a valuable and easy to handle immuno-
histochemical tool. The in situ hybridization signal for ED-B
fibronectin was confined to focal accumulations of spindle-shaped
stromal cells with abundant cytoplasm. Based on their immuno-
cytochemical findings in stroma cell cultures of breast carcinomas,
Brouty-Boyé and Magnien (1994) suggested that the stromal
myofibroblasts were the source of ED-B fibronectin in malignant
tumours. Indeed, the ED-B fibronectin in situ hybridization
labelled stromal cells show myofibroblastic features by light
microscopy. As previously demonstrated also in palmar fibro-
matosis (Dupuytren’s disease), myofibroblasts abundantly synthe-
size ED-B fibronectin (Kosmehl et al, 1995b).
A correlation of the number of ED-B fibronectin-positive
stromal cells to malignancy grade could not be detected. The focal
accumulations of ED-B fibronectin synthesizing cells were found
in the stromal compartment of papillary projections of highly
differentiated carcinomas (area of stroma formation), or in stromal
areas with a parallel alignment of fibro-/myofibroblasts (desmo-
plasia). Therefore, ED-B fibronectin synthesis may indicate
stroma recruitment inclusive of active desmoplastic stroma reac-
tion. The high ED-B fibronectin synthesis during the formation of
an aligned fibrocollagenous stroma concurs with the observation
of Nickeleit et al (1995), who found the strongest ED-B
fibronectin in situ hybridization signal during the sclerosis stage of
experimental autoimmune glomerulonephritis in rats. Moreover,
single spindle-shaped cells and groups of inflammatory cells posi-
tive for ED-B fibronectin synthesis occur regularly at the invasion
front. An expression of ED-B fibronectin in macrophages has
already been described in experimental glomerulonephritis and
granulation tissue (Barnes et al, 1995). Because ED-B fibronectin
enhances adhesion and spreading of several cell types in vitro
(Chen and Culp, 1996; Hashimoto-Uoshima et al, 1997), the ED-B
fibronectin synthesis at the invasion front of OSCC should be
discussed in relation to an altered cellular adhesion, an advance-
ment of cellular migration and formation of an invasive phenotype
(Kosmehl et al, 1996).
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The re-expression of a fetal differentiation pattern in malignant
tumours (so called retrodifferentiation) has been known for nearly
2 decades (Uriel et al, 1979). The embryonic phenotype in malig-
nant tumours entails not only the tumour cells themselves, but
also the extracellular matrix pattern: re-expression of ED-B
fibronectin, de novo glycosylated fibronectin and the laminins-
2,-4, -7 and 11. Whereas laminin synthesis is attributed to the
epithelial (i.e. carcinoma) cells (Pyke et al, 1994; Ueno et al,
1997), the oncofetal ED-B fibronectin matrix is generated by
recruited stromal cells (myofibroblasts), as evinced in this study.
The alternative splicing of fibronectin and the expression of
laminin-5 chains by keratinocytes are regulated by the growth
factor TGFb (Borsi et al, 1990; Berndt et al, 1995; Korang et al,
1995). As a consequence, a co-ordinated extracellular matrix
remodelling in the carcinoma invasion front may be suggested.
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